bicalutamide has been researched along with veliparib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Guan, X; Jin, J; Luo, J; Shi, Y; Sun, Z; Xu, J; Yang, F; Zhang, W | 1 |
2 other study(ies) available for bicalutamide and veliparib
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.
Topics: Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blotting, Western; BRCA1 Protein; Cell Line; Cell Line, Tumor; Cell Survival; Female; Flow Cytometry; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Poly (ADP-Ribose) Polymerase-1; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tosyl Compounds; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2016 |